Type I interferon dysregulation and neurological disease

被引：0
|
作者：
Sarah McGlasson
Alexa Jury
Andrew Jackson
David Hunt
机构：
[1] MRC Human Genetics Unit,
[2] MRC Institute of Genetics and Molecular Medicine,undefined
[3] University of Edinburgh,undefined
来源：
Nature Reviews Neurology | 2015年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Type I interferon is an essential component of the innate immune system, which protects the brain against viral infectionUnderactivity of the type I interferon pathway causes predisposition to herpes simplex encephalitisOveractivity of the type I interferon pathway results in a spectrum of Mendelian neuroinflammatory diseases known as 'interferonopathies'Dysregulation of the type I interferon response has an important role in the pathogenesis of more common diseases that can affect the brain, including lupus and cerebrovascular diseaseAberrant activation of the type I interferon pathway offers potential as a useful biomarker and a target for therapy
引用
收藏
页码：515 / 523
页数：8
相关论文
共 50 条
  • [31] Systemic Lupus Erythematosus - A Disease with A Dysregulated Type I Interferon System
    Hagberg, N.
    Roennblom, L.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2015, 82 (03) : 199 - 207
  • [32] Interferon type I signature associated with skin disease in juvenile dermatomyositis
    Raupov, Rinat
    Suspitsin, Evgeny
    Preobrazhenskaya, Elena V.
    Kostik, Mikhail
    FRONTIERS IN MEDICINE, 2024, 11
  • [33] Type I interferon and lupus
    Ronnblom, Lars
    Alm, Gunnar V.
    Eloranta, Maija-Leena
    CURRENT OPINION IN RHEUMATOLOGY, 2009, 21 (05) : 471 - 477
  • [34] Type I interferon and cancer
    Holicek, Peter
    Guilbaud, Emma
    Klapp, Vanessa
    Truxova, Iva
    Spisek, Radek
    Galluzzi, Lorenzo
    Fucikova, Jitka
    IMMUNOLOGICAL REVIEWS, 2024, 321 (01) : 115 - 127
  • [35] Type I Interferon Drives the Dysregulation of Plasmacytoid and Myeloid Dendritic Cells in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
    van den Hoogen, Lucas L.
    Pandit, Aridaman
    Palla, Giovanni
    Rossato, Marzia
    Fritsch-Stork, Ruth D. E.
    van Roon, Joel A. G.
    Radstake, Timothy R. D. J.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [36] NOVEL PATHOGENETIC MECHANISMS MEDIATED BY DYSREGULATION OF TRIM21-STING-TYPE I INTERFERON AXIS IN LUPUS
    Park, H. W.
    Kim, D. S.
    Park, Y.
    Cho, M. L.
    Kwok, S. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 204 - 204
  • [37] The neurological manifestations of Gaucher's disease type I: The French Observatoire on Gaucher disease (FROG)
    Cherin, P.
    Rose, Ch
    De Roux, Serratrice Ch
    Dobbelaere, D.
    Grosbois, B.
    Hachulla, E.
    Jaussaud, R.
    Javier, R. M.
    Noel, E.
    Clerson, P.
    Hartmann, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 99 - 99
  • [38] Opposing and disease stage specific activity of interferon gamma in EAE modulated by type I interferon signals
    Chander, Raman
    Rodrigo, Naves
    Preet, Singh Simer
    Kevin, Cashman
    Robert, Axtell
    Lawrence, Steinman
    Patrizia, De Sarno
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 111 - 111
  • [39] Type I and type III interferon in opposition?
    Park M.D.
    Nature Reviews Immunology, 2020, 20 (7) : 406 - 406
  • [40] The Role of Type I Interferon Subtypes and Interferon-Gamma in Type I Interferon Diabetes Inhibitory Activity in the NOD Mouse
    Sobel, Douglas
    Ahvazi, Behrouz
    Pontzer, Carol
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (04): : 238 - 246
12345